For many years, there have been raucous debates about the implications of medical device, pharmaceutical and other medical products companies providing payments or gifts to physicians and hospitals. While there have been sporadic attempts at both the state and federal level to address such payments and gifts through reporting and disclosure laws, a national approach was not established until the Physician Payment Sunshine Act was promulgated in 2010, which sets forth comprehensive disclosure and reporting rules applicable to many participants in the health care and bioscience sectors.
To view this content, please continue to Lexis Advance®.
Not a Lexis Advance® Subscriber? Subscribe Now
LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.
ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.
For questions call 1-877-256-2472 or contact us at firstname.lastname@example.org